article published online: 16 march 2015 | doi: 10.1038/nchembio.1774 O-GlcNAc occurs cotranslationally to stabilize nascent polypeptide chains Yanping Zhu1,2, Ta-Wei Liu1,2, Samy Cecioni2, Razieh Eskandari2, Wesley F Zandberg2 & David J Vocadlo1,2* npg © 2015 Nature America, Inc. All rights reserved. Nucleocytoplasmic glycosylation of proteins with O-linked N-acetylglucosamine residues (O-GlcNAc) is recognized as a conserved post-translational modification found in all metazoans. O-GlcNAc has been proposed to regulate diverse cellular processes. Impaired cellular O-GlcNAcylation has been found to lead to decreases in the levels of various proteins, which is one mechanism by which O-GlcNAc seems to exert its varied physiological effects. Here we show that O-GlcNAcylation also occurs cotranslationally. This process protects nascent polypeptide chains from premature degradation by decreasing cotranslational ubiquitylation. Given that hundreds of proteins are O-GlcNAcylated within cells, our findings suggest that cotranslational O-GlcNAcylation may be a phenomenon regulating proteostasis of an array of nucleocytoplasmic proteins. These findings set the stage to assess whether O-GlcNAcylation has a role in protein quality control in a manner that bears similarity with the role played by N-glycosylation within the secretory pathway. H undreds of nuclear and cytoplasmic proteins are posttranslationally modified with N-acetylglucosamine mono saccharide units O-linked to serine or threonine residues of proteins. This modification, known as O-GlcNAc1, is conserved among multicellular eukaryotes, where it regulates diverse cellular processes including, for example, epigenetic regulation of gene expression2–4, stress response5,6 and circadian rhythm7,8. Remarkably, O-GlcNAc executes its physiological functions in part by regulating the levels of various key proteins8–12. In some cases it has emerged that O-GlcNAc influences protein ubiquitylation8–12, but knowledge of the various molecular processes by which O-GlcNAc regulates protein levels remains limited. Protein O-GlcNAcylation is regulated by only two enzymes: O-GlcNAc transferase (OGT) installs O-GlcNAc using uridine 5′-diphosphate-N-acetylglucosamine (UDP-GlcNAc) as a donor substrate13,14, and O-GlcNAcase (OGA) removes O-GlcNAc15. These two enzymes act together to dynamically modulate the levels of O-GlcNAc on proteins within cells. Notably, no consensus sequence governing which residues are O-GlcNAcylated has been found, and structures of human OGT reveal a long binding cleft, suggesting that only extended polypeptide substrates can be O-GlcNAcylated16. Given these data, as well as the observation that OGT stably interacts with actively translating ribosomes17, we considered whether nascent chains emerging from the ribosome might be cotranslationally O-GlcNAcylated. Although O-GlcNAc is accepted as a post-translational modification, we found this hypothesis intriguing given the pleiotropic effects associated with decreased O-GlcNAcylation. Further, considering recent reports that have shown a large fraction of nascent polypeptides are cotranslationally degraded, a process that contributes both to protein quality control and proteostasis18–20, we speculated that if cotranslational O-GlcNAcylation occurs it could have an important role in governing the fate of nascent polypeptides of a subset of nucleocytoplasmic proteins. Using the known O-GlcNAcylated model proteins specificity protein (Sp1) and nuclear pore protein p62 (Nup62), we report that O-GlcNAcylation occurs cotranslationally within both a cell-free expression system and cells. We further find that cotranslational O-GlcNAcylation protects nascent polypeptide chains of Sp1 and Nup62 from premature proteasomal degradation by decreasing cotranslational ubiquitylation. Considering that hundreds of proteins are O-GlcNAcylated within cells, our data indicate that cotranslational O-GlcNAcylation may be a common phenomenon regulating proteostasis of a subset of O-GlcNAcylated nucleocytoplasmic proteins. RESULTS Sp1 is cotranslationally O-GlcNAcylated in vitro To first test whether OGT can cotranslationally O-GlcNAcylate proteins, we selected proteins known to be constitutively O-GlcNAcylated as extensive glycosylation reasonably suggests a functionally important role. We therefore chose Sp1 as it is highly O-GlcNAcylated, and its glycosylation status regulates its cellular levels21,22. Six sites of O-GlcNAcylation are known on Sp123,24 that are mostly in regions of intrinsic disorder. We used rabbit recticulocyte (RR) lysate as a cell-free expression system that contains all the cellular machinery for protein production and processing and is also capable of producing O-GlcNAcylated proteins25. To sensitively monitor O-GlcNAcylation on nascent polypeptides, we used uridine 5′-diphosphate-N-azidoacetylglucosamine (UDP-GlcNAz), a close analog of UDP-GlcNAc that has a small pendent azide functionality. OGT accepts UDP-GlcNAz as a substrate, leading to formation of O-GlcNAz–modified proteins26. Using the Staudinger ligation, a highly chemoselective reaction27, the azide group can be exclusively tagged within RR lysates by using a biotin-modified triarylphosphine substituted at one aryl ring with an ortho-substituted methyl ester. For these studies, we synthesized a phosphine probe containing a cleavable linker (biotin-diazo-phosphine probe 1; Fig. 1a; see Supplementary Results, Supplementary Note for details of the synthesis and characterization). Using these tools, we supplemented lysates with polymerase, UDP-GlcNAz and a plasmid encoding N-terminally Flag-tagged Sp1 and then incubated these samples for various times. By using cetrimonium bromide (CTAB) fractionation, we separated peptidyl-tRNAs from mature proteins released from the ribosome (Fig. 1b). This method permitted us to detect nascent Sp1 peptidyl-tRNAs in the precipitates, as expected (Fig. 1c), whereas mature full-length Sp1 protein was only detected in the supernatants (Supplementary Fig. 1a), indicating that the fractionation method was effective. By tagging glycosylated proteins obtained from CTAB precipitates using the Staudinger ligation, we were able to observe time-dependent changes in the mass of Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada. 2Department of Chemistry, Simon Fraser University, Burnaby, British Columbia, Canada. *e-mail: [email protected] 1 nature CHEMICAL BIOLOGY | VOL 11 | MAY 2015 | www.nature.com/naturechemicalbiology 319 article Nature chemical biology doi: 10.1038/nchembio.1774 other proteins that are not O-GlcNAcylated, we assessed the expression in RR lysates of the O N PPh cytoplasmic protein FBXO22 and Clusterin, HO O O HN NH a protein expressed in the secretory pathN N H H H H way, neither of which are O-GlcNAcylated. N N O O O S We found that the levels of these proteins O O 1 produced were unchanged by OGT inhibib tion (Supplementary Fig. 1c), indicating that 5′ 5′ 40S 40S OGT inhibition does not influence the general tRNA 60S 60S G Staudinger transcriptional or translational machinery 3′ 3′ G OGT ligation G CTAB-PPT within RR lysates responsible for the producG G Biotin Nascent UDP-GlcNAz Phosphine tion of these proteins. To determine whether G O-GlcNAz polypeptide biotin probe (1) these observations stemmed from indirect effects of OGT inhibition leading to decreased O-GlcNAc on components of the ubiquitinCTAB-nascent Flag-Sp1 chain precipitates proteasome system30, we blocked O-GlcNAc c cycling in both directions by simultaneously Time (min): 0 15 30 60 90 0 15 30 60 90 0 15 30 60 90 adding high concentrations of both OGA and 170 130 OGT inhibitors before initiating translation. * * 100 * Upon inhibiting both OGA and OGT within 70 lysates, we found no change in the amount 55 of mature Sp1 produced relative to that pro40 duced with OGT inhibition alone, indicating 35 that only OGT-catalyzed O-GlcNAcylation of 25 newly synthesized polypeptides influences Sp1 stability (Supplementary Fig. 1d). Together, 15 these results indicate that Sp1 is either rapidly MW (kDa) Flag Strvn Merge degraded upon release from the ribosome or that Sp1 nascent polypeptide chains are Figure 1 | Sp1 is cotranslationally O-GlcNAcylated in a cell-free expression system. (a) Structure cotranslationally degraded. On examination of the biotin-diazo-phosphine probe 1. (b) Schematic of the experimental design. (c) Immunoblot of immunoblots, we noted that a range of analysis of CTAB precipitates using anti-Flag antibody and fluorescent streptavidin (Strvn). Sp1 lower-abundance Sp1 polypeptides of smaller expression in RR lysates was performed by incubating plasmid, T7 polymerase and UDP-GlcNAz mass (<100 kDa) were absent upon OGT at 30 °C for the indicated times. Asterisks represent full-length Sp1. MW, molecular weight; inhibition (Fig. 2a) but were observed when PPT, precipitation. See Supplementary Figure 9 for uncut gel images. both OGT and the proteasome were inhibited immunoreactive nascent Sp1 polypeptides that bear both O-GlcNAz (Fig. 2b). We speculated these shorter Sp1 polypeptides might be and the Flag epitope (Fig. 1c). The levels of Sp1 nascent chains nascent chains that, without O-GlcNAcylation, are cotranslationally increased during early time points but gradually decreased after degraded. To test this hypothesis, we stopped translation at an early 30 min, whereas mature full-length Sp1 proteins within the super- time point when nascent chains are abundant (15 min; Fig. 2c) and natant increased over time (Fig. 1c and Supplementary Fig. 1a). found, by immunoprecipitation, an array of truncated Sp1 polypepThese data indicate that O-GlcNAz is cotranslationally installed and tides except in the reaction containing OGT inhibitor. Inhibition of that incorporation of O-GlcNAz does not impair the production of both OGT and the proteasome resulted, however, in levels of these shorter Sp1 polypeptides that are comparable to those seen in the full-length Sp1 proteins. control reaction (Fig. 2c). Similarly, by using CTAB precipitation, we observed that OGT inhibitor alone led to an absence of Sp1 O-GlcNAc protects nascent Sp1 from degradation Given that O-GlcNAc can influence protein stability8–12 and that peptidyl-tRNAs (Fig. 2d). We also found that OGT inhibition increased cotranslational O-GlcNAcylation can occur as shown above, we the extent of Sp1 polypeptide polyubiquitination (Supplementary speculated that cotranslational O-GlcNAcylation might regulate Fig. 1e). Collectively, these data show that O-GlcNAcylation prothe production of stable natively O-GlcNAcylated proteins. To tects nascent Sp1 chains from proteasomal degradation. probe this hypothesis, we used inhibitors to manipulate the activities of OGT and OGA in RR lysates. To inhibit OGT, we used uri- Cotranslational O-GlcNAcylation occurs within cells dine 5′-diphosphate (UDP) as well as the substrate analog uridine We next set out to evaluate whether cotranslational O-GlcNAcylation 5′-diphosphate 2-acetamido-2-deoxy-5-thio-D-glucopyranose (UDP- occurs within cells. We therefore performed transfection of 5SGlcNAc, referred to throughout as UDP-5SInh)28. To inhibit HEK293 cells with plasmids encoding either N-terminally 3× OGA-catalyzed removal of O-GlcNAc, we used Thiamet-G29. We Flag-tagged Sp1 or Nup62. Nup62 was selected as a second model found that OGT inhibition resulted in near absence of mature protein because it is an excellent substrate for OGT in vitro and is full-length Sp1 (Fig. 2a), whereas OGA inhibition had no effect both heavily and rapidly modified with O-GlcNAc31. This protein (Supplementary Fig. 1b). To test whether the observed decrease in is constitutively O-GlcNAcylated and has been proposed to have mature Sp1 might be due to a failure in transcription or translation over ten O-GlcNAc sites32,33, two of which are mapped to residues rather than proteasomal degradation, we concomitantly inhibited the T373 and S468 (Uniprot). We treated these transfected cells overproteasome and OGT. This treatment resulted in Sp1 levels that were night with acetylated N-azidoacetylgalactosamine (Ac4GalNAz), equivalent to those seen in the absence of OGT inhibitor (Fig. 2b). which is biosynthetically converted into UDP-GlcNAz, leading to OGT-catalyzed O-GlcNAcylation is therefore essential for efficient the formation of O-GlcNAz on proteins34. The following day, after production of Sp1 in vitro in a cell-free system, and, in the absence transfection and Ac4GalNAz treatment, ribosome-bound nascent of O-GlcNAc, Sp1 is rapidly degraded by the ubiquitin-proteasome Sp1 polypeptides were purified by isolation of polysomes followed system. To evaluate whether OGT inhibition might have effects on by immunoprecipitation of Flag-tagged peptides. After tagging of a O Br N N O H N npg © 2015 Nature America, Inc. All rights reserved. 320 Flag Flag Flag Flag Biot in 2 nature chemical biology | VOL 11 | MAY 2015 | www.nature.com/naturechemicalbiology article Nature chemical biology doi: 10.1038/nchembio.1774 a Time (min): b 5 10 30 Time (min): 90 UDP-5SInh – + – – + – – + – – + – UDP – – + – – + – – + – – + MW (kDa) 170 130 100 5 10 © 2015 Nature America, Inc. All rights reserved. 90 UDP-5SInh – + – – + – – + – – + – MG132 – + – – + – – + – – + – UDP – – + – – + – – + – – + MW (kDa) 170 130 100 70 70 55 55 O-GlcNAc is removed following completion of translation and release of the mature protein. This observation further suggests that cotranslational O-GlcNAcylation may have a functional role on nascent chains. O-GlcNAc moderates cotranslational ubiquitination in cells Given that both O-GlcNAc and ubiquitin are found on nascent chains within cells and that O-GlcNAcylation regulates their sta– – + + – – UDP-5SInh – – + + – – UDP-5SInh + + – – + MG132 MW (kDa) – MW (kDa) – + + – – + MG132 bility in vitro on Sp1, we were interested in 100 170 whether cotranslational O-GlcNAcylation 70 130 contributes to the stability of nascent chains 100 55 70 in cells. To block OGT activity in cells, we 40 55 used acetylated 5-thio-N-acetylglucosamine 40 35 (Ac45SGlcNAc, referred to throughout as 35 25 5SInh), which is transformed by the cellular 15 machinery to generate the OGT inhibitor 25 UDP-5SGlcNAc28. Using this tool compound, CTAB-PPT/Flag-IB Flag-IP/Flag-IB we found that OGT inhibition resulted in decreased O-GlcNAcylation of nascent chains Figure 2 | Nascent Sp1 polypeptides are stabilized by cotranslational O-GlcNAcylation in of Sp1 and Nup62 as well as lower overall levels a cell-free system. (a) Effect of OGT inhibitors UDP-5SGlcNAc (UDP-5SInh) or UDP on the of Flag-tagged nascent chains of these proteins time-dependent production of Sp1. MW, molecular weight. (b) Effect of proteasome inhibition (Fig. 3a and Supplementary Fig. 2a). Levels (MG132) on the levels of Sp1 produced under different conditions. (c) Immunoblot (IB) analysis of of Sp1 nascent chains were decreased by immunoprecipitated (IP) Flag-tagged Sp1 from RR lysates in which translation was stopped by the approximately 50% in cells yet were not comaddition of cycloheximide 15 min after the initiation of the expression reaction. (d) Immunoblot pletely absent, as observed in the cell-free analysis of Flag-tagged Sp1 nascent chains within CTAB precipitates of nascent Sp1 peptidylsystem. This difference most likely stems tRNAs that were obtained from RR lysates in which translation was stopped after 15 min by the from incomplete inhibition of OGT within addition of cycloheximide. PPT, precipitatation. cells as compared to lysates, which is apparent when examining the residual level of O-GlcNAz–modified nascent chains with the biotin-diazo-phosphine O-GlcNAcylation of Sp1 in cells treated with OGT inhibitor probe, we observed that anti-Flag– and streptavidin–reactive (Fig. 3a). Regardless, these data clearly showed that OGT inhibition bands were largely coincident, indicating that ribosome-bound Sp1 decreased levels of nascent chains of both Sp1 and Nup62 within and Nup62 can be cotranslationally O-GlcNAcylated within cells cells. To test whether the decreased levels of these nascent chains having lower O-GlcNAcylation stemmed from their proteasomal (Fig. 3a and Supplementary Fig. 2a). Notably, we found within polysome fractions a substantial degradation, as we hypothesized, we simultaneously inhibited both portion of the proteins having a molecular weight close to that of the proteasome and OGT within cells. This concomitant inhibition full-length Sp1 or Nup62 (Fig. 3a and Supplementary Fig. 2a). To resulted in levels of Sp1 and Nup62 nascent chains that were equivclarify whether these long polypeptides were also ribosome-bound alent to those seen in control cells (Fig. 4a and Supplementary nascent chains or represented contamination of the polysome frac- Fig. 2b), which is in alignment with data from the cell-free tion with mature full-length proteins, we performed an additional system. These data indicate that cotranslational O-GlcNAcylation fraction step. The isolated polysome preparation was fractionated stabilizes nascent chains against cotranslational proteasomal using CTAB to obtain peptidyl-tRNAs, after which we performed degradation both in vitro and in cells. immunoprecipitation of Flag-Nup62. Using this approach, we Given our findings regarding stabilization of nascent chains again observed these long polypeptide chains, indicating that these by cotranslational O-GlcNAcylation, we were intrigued by recent species were nascent chains linked to the ribosome and not reports showing that cotranslational ubiquitylation labels a large contaminating mature proteins (Supplementary Fig. 3). fraction of nascent polypeptides for degradation19,20. We hypothesized that the enhanced cotranslational degradation of nascent Nascent Sp1 is more heavily O-GlcNAcylated than mature Sp1 chains of Sp1 and Nup62 observed when OGT was inhibited might Given that O-GlcNAc is installed cotranslationally but is a reversible stem from their increased cotranslational ubiquitylation. To test this modification, we were curious about the abundance of O-GlcNAc hypothesis, we analyzed the ubiquitin levels of ribosome-bound Sp1 on nascent chains as compared to mature proteins as it is conceiv- and Nup62 nascent polypeptides from cells treated with proteasome able that glycosylation may either increase or decrease over time. inhibitor alone and cells treated with both proteasome and OGT We therefore analyzed the extent of O-GlcNAz present on nascent inhibitors. We again noted that proteasome inhibition led to equivachains and mature proteins by quantifying the immunoreactivity of lent levels of these proteins being produced and that concomitant these species following isolation of Flag-tagged species. Remarkably, inhibition of OGT resulted in increased ubiquitylation of these proby comparing the level of O-GlcNAz present on different species of teins as compared to control cells that were not treated with OGT Sp1 polypeptide chains (O-GlcNAz/Flag-Sp1), we found that Sp1 inhibitor (Fig. 4a and Supplementary Fig. 2b). As an alternative nascent chains were more extensively modified with O-GlcNAz approach to address this question, we assessed the effect of reduced compared to mature proteins isolated from polysome-free fractions. O-GlcNAcylation on Sp1 nascent chains in mouse embryonic fibroShort nascent chains of Sp1 in particular had robustly higher levels blasts (MEFs) in which the ogt gene can be inducibly excised35. Here of O-GlcNAz than full-length Sp1 nascent chains (Fig. 3b). This we found that loss of OGT resulted in decreased levels of Sp1 nascent line of data indicates that O-GlcNAc is added cotranslationally to chains. When the OGT gene was excised in the presence of proteaSp1 and that a considerable fraction of the cotranslationally added some inhibitor, we observed an increase in the extent of nascent Sp1 Flag Flag c npg 30 With plasmid No plasmid d With plasmid No plasmid nature CHEMICAL BIOLOGY | VOL 11 | MAY 2015 | www.nature.com/naturechemicalbiology 321 article Nature chemical biology doi: 10.1038/nchembio.1774 a + – + + – – + – + + – – + – + + npg © 2015 Nature America, Inc. All rights reserved. Relative O-GlcNAz levels (O-GlcNAz/Sp1) _ NC S _F L NC NC M P Relative O-GlcNAz levels (O-GlcNAz/Sp1) Relative O-GlcNAz levels (O-GlcNAz/Sp1) 3 22 Co nt ro l 5S In h – – NC _F M L P_ FL + + Co nt ro l 5S In h + – Relative nascent Sp1 levels (Nascent Sp1/RPS6) – – Relative O-GlcNAz levels on nascent Sp1 (O-GlcNAz/Sp1) involved in regulating cellular ubiquitination are known to be O-GlcNAcylated, we MW (kDa) 1.5 1.5 considered that these might be influenced by 100 O-GlcNAcylation12,36 and therefore performed 70 * * * 1.0 1.0 further control experiments. To assess whether 55 * * * * * * * ** 40 reduced O-GlcNAcylation upon OGT inhibi35 0.5 0.5 * * * 25 tion alters the activity of ubiquitin systems * * * Flag Flag-LE Strvn Merge within cells, we analyzed global protein ubiq0 0 uitylation levels in cells and found that these were unaffected (Supplementary Fig. 5), RPS6-Input suggesting that the effects observed on Sp1 and Nup62 ubiquitylation did not stem from b NC MP NC MP NC MP NC MP MW (kDa) alterations in the general activity of the cellular NC_FL 1.5 100 1.5 1.5 ubiquitylation machinery. Finally, we further ** ** 70 ** tested whether it is direct O-GlcNAcylation 1.0 1.0 55 1.0 that affects the stability of Sp1 and Nup62 * * * 40 ** * nascent chains by generating mutants of these NC_S * * 0.5 0.5 0.5 35 * * * two proteins in which known O-GlcNAc sites *** ** * * 25 * 0 0 0 were eliminated by site-directed mutagenesis. 15 Known O-GlcNAcylation sites of Sp1 include Flag Flag-LE Strvn Merge residues S491, S612, T640, S641, S698 and Figure 3 | Cotranslational O-GlcNAcylation of Sp1 stabilizes nascent polypeptides within cells. S702, of which S491, S612, S698 and S702 (a) Sp1 is O-GlcNAcylated cotranslationally, and levels of Sp1 nascent chains are reduced are found in regions of intrinsic disorder. For upon inhibition of OGT in cells. 24 h after transfection with 3× Flag-tagged Sp1, HEK293 cells Nup62, the known sites of glycosylation include were treated with Ac4GalNAz with or without Ac45SGlcNAc (5SInh) overnight. Nascent T373 and S468, of which S468 is found in a Flag-tagged Sp1 immunoprecipitated from equal amounts of isolated polysomes were reacted disordered region. These mutant proteins all with the biotin-diazo-phosphine probe 1 overnight. Samples were then probed using anti-Flag showed reductions in their O-GlcNAcylation antibody and streptavidin (Strvn). Immunoblots of RPS6 were used to control for sample input. levels, either as a trend or at a significant level The asterisks indicate coincident anti-Flag– and streptavidin-reactive bands. Values of O-GlcNAz (Supplementary Fig. 6). We also found that signals were normalized to corresponding Flag immunoblot signals, whereas nascent Flag-Sp1 loss of these O-GlcNAc sites increased the levsignals were normalized to corresponding RPS6 immunoblot signals. All of the samples were els of cotranslational ubiquitylation of nascent normalized to the corresponding control, arbitrarily set as 1. Error bars represent ±s.d. *P < 0.05, Sp1 and Nup62 chains compared to that of **P < 0.01 by paired Student’s t-test (n = 3). MW, molecular weight. (b) Analysis of the levels wild-type proteins (Fig. 4b and Supplementary of O-GlcNAz on Sp1 nascent chains as compared to mature Sp1 proteins. Cells were treated Fig. 2c). Furthermore, we were interested in as in a, except that 5SInh was not added. Sp1 nascent chains were immunoprecipitated from whether increased cotranslational ubiquitylaisolated polysomes, and mature Sp1 proteins were immunoprecipitated from the polysome-free tion on nascent chains of these Sp1 mutants supernatant fractions. Values of O-GlcNAz signals were normalized to corresponding Flag would increase their susceptibility to proteaimmunoblot signals and then normalized again to the corresponding control, arbitrarily set as 1. somal degradation, as seen when OGT inhibiError bars represent ±s.d. **P < 0.01, ***P < 0.001 by paired Student’s t-test (n = 3). NC, nascent tor was used to decrease O-GlcNAcylation of chain; NC_S, nascent short chain; NC_FL, nascent chain full length; MP, mature protein; Sp1. To this end, we treated cells expressing MP_FL, mature protein, full length; LE, long exposure; RPS6, ribosomal protein S6. Sp1 and these Sp1 mutant proteins with proteasome inhibitor or vehicle. We anticipated that if the proteosomal susceptibility of nascent ubiquitination (Supplementary Fig. 4a). Notably, we observed by chains of Sp1 mutants were increased as compared to wild-type Sp1, immunoblotting that some OGT remained in the knockout cell line proteasome inhibition would lead to greater increases in the levels of (Supplementary Fig. 4a), perhaps because OGT has a long half-life. mutant Sp1 chains compared to chains of wild-type Sp1. Consistent This remaining OGT may be part of the reason why Sp1 nascent with our hypothesis, we found that proteasome inhibition resulted chains were not completely absent, as observed in the cell-free in restoration of the levels of both long and short nascent chains system. Regardless, the data obtained using this genetic approach of Sp1 mutants, with a much smaller effect for wild-type Sp1 (Fig. 4c and Supplementary Fig. 7). These data indicate that are similar to those seen when inhibiting OGT in cells. We next performed a series of control experiments to exclude nascent chains of Sp1 O-GlcNAc–deficient mutants were more possible off-target effects of the inhibitors used as well as to test extensively degraded by the proteasome as compared to nascent whether the effects observed were mediated by direct action of chains of wild-type Sp1, which is in keeping with their increased OGT on Sp1 and Nup62 nascent chains. First, to evaluate whether ubiquitylation. Collectively, these data reveal that the direct MG132 might have off-target effects that could confound our activity of OGT to cotranslationally O-GlcNAcylate Sp1 and Nup62 results, we repeated several experiments using the structurally dis- protects nascent chains of these proteins against cotranslational tinct proteasome inhibitor lactacystin. Using this tool compound, ubiquitylation and downstream proteasomal degradation. we observed results consistent with the findings made using MG132 (Supplementary Fig. 4b), indicating that our observations did not O-GlcNAcylation stabilizes mature Sp1 stem from potential off-target effects of MG132. Next, consistent Given that O-GlcNAc modification has been proposed to modulate with the direct action of OGT on Sp1 regulating Sp1 levels rather the levels of Sp1 in cells21, we wanted to address whether, in addithan indirect action on the general transcriptional or translational tion to protection at the cotranslational level, there was also regulamachinery in cells, we found that OGT inhibition had no effect on tion at the post-translational level. To this end, we isolated mature the levels of nascent chains of the cytoplasmic non–O-GlcNAcylated Sp1, which had been released from ribosomes, from polysome-free protein FBXO22 or on the extent of FBXO22 ubiquitination fractions. We found that ubiquitinylation of mature Sp1 in cells (Supplementary Fig. 4c,d). Nevertheless, because various proteins treated with OGT inhibitor were clearly elevated compared to levels Flag-Sp1 5SInh nature chemical biology | VOL 11 | MAY 2015 | www.nature.com/naturechemicalbiology article + + – 5SInh + – – + – – + – – Mr (kDa) 170 130 100 70 Flag Flag-LE HA-Ub 55 RPS6-Input b 1.5 NS 1.0 0.5 0 * 4 3 2 1 0 S612A T640A S641A S698A S702A 2.5 3 2 * 1 0 more rapidly than degradation of the wild-type proteins. We therefore tracked the degradation rates of these mutants by cycloheximide chase and found, as predicted, that these Sp1 mutants were degraded more quickly than the corresponding wild-type proteins (Supplementary Fig. 8c,d). These data therefore provide good evidence that O-GlcNAcylation can regulate both the co- and post-translational stability of Sp1, suggesting that O-GlcNAc may function throughout the lifetime of Sp1 to protect it from degradation via the ubiquitinproteasome pathway. DISCUSSION 2.0 * NS NS NS ** * ** ** npg A 40 A S6 41 A A 12 02 S6 S7 A 12 S6 S6 12 A T6 40 A S6 41 A S6 T6 98 A W T Increase in nascent Sp1 level (Sp1-MG132/Sp1-No MG132) T6 40 T6 W S4 T 91 A S6 A 4 S6 S 0A 12 S6 41 69 S A 12 S6 A S 8A 64 A 12 69 S7 1A T6 40 S6 A T 8A 02 A 12A 64 S7 A S6 S 0A 02 41 69 S A A 8 64 S6 A 1A 98 S70 A 2A S7 02 A T640A S698A WT S491A S612A S641A S702A Relative HA-Ub levels (HA-Ub/Sp1) Using model proteins, we have found that O-GlcNAcylation occurs not only post1.5 translationally, as previously thought, but also 170 1.0 cotranslationally. Notably, levels of cotrans130 HA-Ub 0.5 lational O-glycosylation by O-GlcNAc on 100 0 nascent chains are higher than those found on 70 the corresponding mature proteins. This obser100 vation on its own suggests that cotranslational Flag O-GlcNAcylation most likely has a functional 70 role. Indeed, here we found that cotranslational O-GlcNAcylation regulated the stability c of nascent chains by decreasing their cotranslaMG132 – + – + – + – + tional ubiquitylation (Fig. 5) as well as by regS612A S612A 4 T640A T640A ulating Sp1 levels at the post-translational level ** * S641A S641A S612A S612A 3 through ubiquitylation. Previous research has S698A S698A T640A T640A MW (kDa) WT WT S612A S612A S702A S702A S641A S641A suggested that O-GlcNAc functions to post2 130 NS translationally regulate the susceptibility of 100 1 proteins including Snail-1 (ref. 11), β-catenin9, 70 Sp1 (ref. 21), clock8 and Δ-lactoferrin37 toward Flag 0 55 proteasomal degradation. Glucose starvation coupled with stimulation using cyclic AMP 40 results in rapid proteasomal degradation of 35 Sp1, suggesting that O-GlcNAc protects Sp1 from proteosomal degradation through an RPS6 undefined mechanism21. Our results suggest that these previous findings regarding Sp1 Figure 4 | Cotranslational O-GlcNAcylation of Sp1 stabilizes nascent polypeptides from may in part be accounted for by cotranslapremature proteasomal degradation within cells. (a) Immunoblot analysis of ubiquitinylation tional O-GlcNAcylation acting to protect both levels of nascent Sp1 in proteasome inhibited cells in the presence and absence of OGT inhibitor. nascent chains and mature Sp1 from premaCells were treated as in Figure 3a except that the plasmid pRK5-HA-ubiquitin, which encodes ture proteosomal degradation by attenuating ubiquitin with an N-terminal hemagglutinin tag (HA-Ub), was cotransfected into cells. their ubiquitination. Nascent Flag-Sp1 polypeptides immunoprecipitated were probed using anti-HA antibody Accordingly, defining precisely how to detect ubiquitinylation (Ub). RPS6 was used as a measure for control of sample input. O-GlcNAc decreases cotranslational ubiquiError bars represent ±s.d. *P < 0.05 from paired Student’s t-test (n = 3). LE, long exposure. tylation of specific proteins will be of interest. (b) Analysis of the level of ubiquitinylation of nascent polypeptides of Flag-Sp1 in which O-GlcNAc may, for example, block cotransdifferent known O-GlcNAc sites were deleted by site-directed mutagenesis. Error bars lational ubiquitylation, by recruiting proteins represent ±s.d. *P < 0.05, **P < 0.01, as calculated with one-way analysis of variance (n = 3). that protect nascent chains by directly blockMW, molecular weight. (c) Analysis of the levels of nascent Sp1 polypeptides obtained from ing substrate recognition by ubiquitin ligases various mutants of Sp1 lacking known O-GlcNAc sites. Relative levels of Sp1 nascent chains or by influencing the folding pathway of were quantified by dividing total Flag immunoreactivity by the corresponding RPS6 natively O-GlcNAcylated proteins such that immunoreactivity. Increases in the relative levels of Sp1 nascent chains upon proteasome nascent chains misfold and are themselves inhibition were calculated by dividing the relative Flag-Sp1 signal (Flag-Sp1/RPS6) from recognized by the ubiquitinylation machinMG132-treated cells by the signal from cells not treated with MG132. Error bars represent ±s.d. ery. Accordingly, future research directed *P < 0.05, **P < 0.01, as calculated with one-way analysis of variance (n = 3). NS, not significant. at identifying the set of cotranslationally O-GlcNAcylated proteins will be of interest, observed in control cells (Supplementary Fig. 8a,b). We next evalu- as will identifying those proteins whose stability is regulated by ated the effects of site-directed mutation of known O-GlcNAcylation cotranslational O-GlcNAcylation. Given the presence of O-GlcNAc sites, and we found that all of the mutants tested showed increased on several hundred cellular proteins38 and the fact that OGT has ubiquitin modification compared with the wild-type proteins been reported to interact stably with ribosomes17, it is probable (Supplementary Fig. 8a,b). On the basis of the data above, we that cotranslational O-GlcNAcylation is common to many proteins. expected that degradation of O-GlcNAc site mutants should occur Seeing as cotranslational O-GlcNAcylation is abundant on these MW (kDa) © 2015 Nature America, Inc. All rights reserved. T640A S641A S612A S612A S698A T640A S698A WT S702A S641A S702A 5 2.0 nt ro l 5S In h + + Co + – Relative polyubiquitinated Sp1 levels (polyubiquitinated Sp1/total Sp1) + + nt ro l 5S In h + + Relative HA-Ub levels (HA-Ub/Sp1) + Co + – nt ro l 5S In h + + Co MG132 + Flag-Sp1 + Polyubiquitinated Sp1 a Relative nascent Sp1 levels (nascent Sp1/RPS6) Nature chemical biology doi: 10.1038/nchembio.1774 nature CHEMICAL BIOLOGY | VOL 11 | MAY 2015 | www.nature.com/naturechemicalbiology 323 npg © 2015 Nature America, Inc. All rights reserved. article Nature chemical biology doi: 10.1038/nchembio.1774 model proteins, it is interesting to speculate 5′ 5′ 40S 40S whether some sites of O-GlcNAc that are Loss of OGT 60S 60S mapped onto proteins stem from cotranslation3′ 3′ function ally installed O-GlcNAc and are residues that O-GlcNAc OGT OGT OGT Inhibitors G or OGT knockout are not removed as proteins mature. Answering G such questions will depend on time-resolved G mapping of O-GlcNAcylation sites on both coNascent Ub polypeptide and post-translationally O-GlcNAcylated proteins. On a more functional level, O-GlcNAc is a cellular stress response6,35 that is also nutrient responsive39–41, and so it seems likely that cotranslational O-GlcNAcylation is an adapProteasome tive response enabling protection of nascent chains during times of stress or high metabolic G flux, a view that is consistent with the protecG G tive effects of increased O-GlcNAc in various G G models42 and the effects of altered O-GlcNAc G levels on the levels of some proteins7–9,37. Worth noting is that protein N-glycosylation Full-length protein within the secretory pathway has been clearly defined over the past two decades as a major Figure 5 | Proposed model for regulation of nascent polypeptide chain stability by factor in protein quality control that helps to cotranslational O-GlcNAcylation. Nascent polypeptides of Sp1 or Nup62 are modified with ensure proper folding of various proteins. O-GlcNAc cotranslationally during their elongation, which can moderate the ubiquitination The loss of N-glycosylation leads to proand prevent subsequent proteasome degradation leading to efficient production of full-length teasomal degradation of many proteins43–46. proteins. In conditions where cotranslational O-GlcNAcylation is blocked by loss of OGT or OGT N-glycosylation has generally been defined as inhibition, nascent polypeptides are more heavily polyubiquitinated and are prematurely degraded occurring cotranslationally47,48. Recent work by the proteasome. has shown, however, that N-glycosylation also occurs post-translationally49 and is essential to ensure functionally important modification of certain glycosylation 8. Li, M.D. et al. O-GlcNAc signaling entrains the circadian clock by inhibiting BMAL1/CLOCK ubiquitination. Cell Metab. 17, 303–310 (2013). sites50. Here we have shown that O-GlcNAcylation can also occur cotranslationally to protect nascent chains from cotranslational 9. Olivier-Van Stichelen, S. et al. O-GlcNAcylation stabilizes β-catenin through direct competition with phosphorylation at threonine 41. degradation, which enables efficient production of the correspondFASEB J. 28, 3325–3338 (2014). ing full-length proteins. The potential parallels between O-GlcNAc 10.Yang, W.H. et al. Modification of p53 with O-linked N-acetylglucosamine and N-glycosylation are notable, suggesting that increased insight regulates p53 activity and stability. Nat. Cell Biol. 8, 1074–1083 (2006). into cotranslational O-GlcNAcylation may uncover that its role in 11.Park, S.Y. et al. Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition. EMBO J. 29, 3787–3796 (2010). protein quality control resembles that of N-glycosylation within the 12.Ruan, H.B., Nie, Y. & Yang, X. Regulation of protein degradation by secretory pathway. O-GlcNAcylation: crosstalk with ubiquitination. Mol. Cell. Proteomics 12, Received 21 December 2014; accepted 13 February 2015; published online 16 March 2015 Methods Methods and any associated references are available in the online version of the paper. References 1. Torres, C.R. & Hart, G.W. Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J. Biol. Chem. 259, 3308–3317 (1984). 2. Gambetta, M.C., Oktaba, K. & Muller, J. Essential role of the glycosyltransferase sxc/Ogt in polycomb repression. Science 325, 93–96 (2009). 3. Hanover, J.A., Krause, M.W. & Love, D.C. Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat. Rev. Mol. Cell Biol. 13, 312–321 (2012). 4. Sinclair, D.A. et al. Drosophila O-GlcNAc transferase (OGT) is encoded by the Polycomb group (PcG) gene, super sex combs (sxc). Proc. Natl. Acad. Sci. USA 106, 13427–13432 (2009). 5. Ohn, T., Kedersha, N., Hickman, T., Tisdale, S. & Anderson, P. A functional RNAi screen links O-GlcNAc modification of ribosomal proteins to stress granule and processing body assembly. Nat. Cell Biol. 10, 1224–1231 (2008). 6. Zachara, N.E. et al. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J. Biol. Chem. 279, 30133–30142 (2004). 7. Kim, E.Y. et al. A role for O-GlcNAcylation in setting circadian clock speed. Genes Dev. 26, 490–502 (2012). 3 24 3489–3497 (2013). 13.Haltiwanger, R.S., Holt, G.D. & Hart, G.W. Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-acetylglucosamine:peptide β-N-acetylglucosaminyltransferase. J. Biol. Chem. 265, 2563–2568 (1990). 14.Lubas, W.A., Frank, D.W., Krause, M. & Hanover, J.A. O-Linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats. J. Biol. Chem. 272, 9316–9324 (1997). 15.Gao, Y., Wells, L., Comer, F.I., Parker, G.J. & Hart, G.W. Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic β-N-acetylglucosaminidase from human brain. J. Biol. Chem. 276, 9838–9845 (2001). 16.Lazarus, M.B., Nam, Y., Jiang, J., Sliz, P. & Walker, S. Structure of human O-GlcNAc transferase and its complex with a peptide substrate. Nature 469, 564–567 (2011). 17.Zeidan, Q., Wang, Z., De Maio, A. & Hart, G.W. O-GlcNAc cycling enzymes associate with the translational machinery and modify core ribosomal proteins. Mol. Biol. Cell 21, 1922–1936 (2010). 18.Bengtson, M.H. & Joazeiro, C.A. Role of a ribosome-associated E3 ubiquitin ligase in protein quality control. Nature 467, 470–473 (2010). 19.Duttler, S., Pechmann, S. & Frydman, J. Principles of cotranslational ubiquitination and quality control at the ribosome. Mol. Cell 50, 379–393 (2013). 20.Wang, F., Durfee, L.A. & Huibregtse, J.M. A cotranslational ubiquitination pathway for quality control of misfolded proteins. Mol. Cell 50, 368–378 (2013). 21.Han, I. & Kudlow, J.E. Reduced O-glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol. Cell. Biol. 17, 2550–2558 (1997). 22.Jackson, S.P. & Tjian, R. Purification and analysis of RNA polymerase II transcription factors by using wheat germ agglutinin affinity chromatography. Proc. Natl. Acad. Sci. USA 86, 1781–1785 (1989). nature chemical biology | VOL 11 | MAY 2015 | www.nature.com/naturechemicalbiology npg © 2015 Nature America, Inc. All rights reserved. Nature chemical biology doi: 10.1038/nchembio.1774 23.Roos, M.D., Su, K., Baker, J.R. & Kudlow, J.E. O-glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions. Mol. Cell. Biol. 17, 6472–6480 (1997). 24.Chung, S.S. et al. Activation of PPARγ negatively regulates O-GlcNAcylation of Sp1. Biochem. Biophys. Res. Commun. 372, 713–718 (2008). 25.Starr, C.M. & Hanover, J.A. Glycosylation of nuclear pore protein p62. Reticulocyte lysate catalyzes O-linked N-acetylglucosamine addition in vitro. J. Biol. Chem. 265, 6868–6873 (1990). 26.Vocadlo, D.J., Hang, H.C., Kim, E.J., Hanover, J.A. & Bertozzi, C.R. A chemical approach for identifying O-GlcNAc–modified proteins in cells. Proc. Natl. Acad. Sci. USA 100, 9116–9121 (2003). 27.Saxon, E. & Bertozzi, C.R. Cell surface engineering by a modified Staudinger reaction. Science 287, 2007–2010 (2000). 28.Gloster, T.M. et al. Hijacking a biosynthetic pathway yields a glycosyltransferase inhibitor within cells. Nat. Chem. Biol. 7, 174–181 (2011). 29.Yuzwa, S.A. et al. A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo . Nat. Chem. Biol. 4, 483–490 (2008). 30.Zhang, F. et al. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115, 715–725 (2003). 31.Davis, L.I. & Blobel, G. Nuclear pore complex contains a family of glycoproteins that includes p62: glycosylation through a previously unidentified cellular pathway. Proc. Natl. Acad. Sci. USA 84, 7552–7556 (1987). 32.Holt, G.D. et al. Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine. J. Cell Biol. 104, 1157–1164 (1987). 33.Rexach, J.E. et al. Quantification of O-glycosylation stoichiometry and dynamics using resolvable mass tags. Nat. Chem. Biol. 6, 645–651 (2010). 34.Boyce, M. et al. Metabolic cross-talk allows labeling of O-linked β-N-acetylglucosamine–modified proteins via the N-acetylgalactosamine salvage pathway. Proc. Natl. Acad. Sci. USA 108, 3141–3146 (2011). 35.Kazemi, Z., Chang, H., Haserodt, S., McKen, C. & Zachara, N.E. O-linked β-N-acetylglucosamine (O-GlcNAc) regulates stress-induced heat shock protein expression in a GSK-3β–dependent manner. J. Biol. Chem. 285, 39096–39107 (2010). 36.Guinez, C. et al. Protein ubiquitination is modulated by O-GlcNAc glycosylation. FASEB J. 22, 2901–2911 (2008). 37.Hardivillé, S., Hoedt, E., Mariller, C., Benaissa, M. & Pierce, A. O-GlcNAcylation/phosphorylation cycling at Ser10 controls both transcriptional activity and stability of Δ-lactoferrin. J. Biol. Chem. 285, 19205–19218 (2010). 38.Hart, G.W., Slawson, C., Ramirez-Correa, G. & Lagerlof, O. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu. Rev. Biochem. 80, 825–858 (2011). 39.Forsythe, M.E. et al. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer. Proc. Natl. Acad. Sci. USA 103, 11952–11957 (2006). 40.Hanover, J.A. et al. A Caenorhabditis elegans model of insulin resistance: altered macronutrient storage and dauer formation in an OGT-1 knockout. Proc. Natl. Acad. Sci. USA 102, 11266–11271 (2005). 41.Hart, G.W., Housley, M.P. & Slawson, C. Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446, 1017–1022 (2007). article 42.Radermacher, P.T. et al. O-GlcNAc reports ambient temperature and confers heat resistance on ectotherm development. Proc. Natl. Acad. Sci. USA 111, 5592–5597 (2014). 43.Helenius, A. & Aebi, M. Roles of N-linked glycans in the endoplasmic reticulum. Annu. Rev. Biochem. 73, 1019–1049 (2004). 44.Trombetta, E.S. & Parodi, A.J. Quality control and protein folding in the secretory pathway. Annu. Rev. Cell Dev. Biol. 19, 649–676 (2003). 45.Moremen, K.W. & Molinari, M. N-linked glycan recognition and processing: the molecular basis of endoplasmic reticulum quality control. Curr. Opin. Struct. Biol. 16, 592–599 (2006). 46.Hebert, D.N., Garman, S.C. & Molinari, M. The glycan code of the endoplasmic reticulum: asparagine-linked carbohydrates as protein maturation and quality-control tags. Trends Cell Biol. 15, 364–370 (2005). 47.Rothman, J.E. & Lodish, H.F. Synchronised transmembrane insertion and glycosylation of a nascent membrane protein. Nature 269, 775–780 (1977). 48.Chen, W., Helenius, J., Braakman, I. & Helenius, A. Cotranslational folding and calnexin binding during glycoprotein synthesis. Proc. Natl. Acad. Sci. USA 92, 6229–6233 (1995). 49.Bolt, G., Kristensen, C. & Steenstrup, T.D. Posttranslational N-glycosylation takes place during the normal processing of human coagulation factor VII. Glycobiology 15, 541–547 (2005). 50.Ruiz-Canada, C., Kelleher, D.J. & Gilmore, R. Cotranslational and posttranslational N-glycosylation of polypeptides by distinct mammalian OST isoforms. Cell 136, 272–283 (2009). Acknowledgments Financial support through a Discovery Grant (grant number: RGPIN/298406-2010) the Natural Sciences and Engineering Research (NSERC) and the Canadian Institutes of Health Research (CIHR; grant number: MOP-123341) is gratefully acknowledged. Y.Z. thanks the CIHR for support through a postdoctoral fellowship. D.J.V. acknowledges the kind support of the Canada Research Chairs program for a Tier I Canada Research Chair in Chemical Glycobiology and NSERC for support as an E.W.R. Steacie Memorial Fellow. S.C. acknowledges the Government of Canada and the CIHR for postdoctoral fellowship support. R.E. acknowledges the Alzheimer Society of Canada and the Michael Smith Foundation for Health Research for postdoctoral fellowship support. Author contributions Y.Z. and D.J.V. designed research; Y.Z. and T.-W.L. performed experiments; R.E. synthesized UDP-GlcNAz; W.F.Z. synthesized UDP-5SGlcNAc; S.C. synthesized the biotin-diazophosphine probe; Y.Z. and D.J.V. wrote the paper; all authors provided input into the manuscript. Competing financial interests The authors declare competing financial interests: details accompany the online version of the paper. Additional information Supplementary information and chemical compound information is available in the online version of the paper. Reprints and permissions information is available online at http://www.nature.com/reprints/index.html. Correspondence and requests for materials should be addressed to D.J.V. nature CHEMICAL BIOLOGY | VOL 11 | MAY 2015 | www.nature.com/naturechemicalbiology 325 ONLINE METHODS Plasmids. Human Sp1, Nup62, FBXO22 and Clu were amplified using synthetic primers to bear N-terminal 3× Flag tags by PCR and then were cloned into pET28a (Novagen) or pCMV-Tag 2A (Agilent) vectors. Plasmid pRK5HA-Ub was obtained from Addgene. npg © 2015 Nature America, Inc. All rights reserved. Western blotting. Protein samples were run in 12% SDS-PAGE gels and subsequently transferred onto nitrocellulose membranes. For more facile detection of polyubiquitinated protein species, samples were run using 4–20% SDS-PAGE gels. Primary antibodies, anti-Flag (Santa Cruz, sc-166355 and sc-807), anti-HA (Santa Cruz, sc-805), anti-actin (Santa Cruz, sc-47778), anti-ubiquitin (Santa Cruz, sc-8017) and anti-RPS6 (Santa Cruz, sc-74459) were all used at between 1:1,000 and 1:2,000 dilution. Appropriate fluorescent secondary antibodies were purchased from Li-Cor and used in 1:20,000 dilution. Images for blots were obtained using an Odyssey Infrared Imaging System (Li-Cor). To better illustrate quantitative differences between several bands having both low and high intensities on one immunoblot for the Flag immunoblots, the immuno blots were scanned at two different intensity settings (3.5 and long exposure 6). In vitro expression. In vitro expression was carried out in TNT-coupled RR lysate (Promega) according to the user’s manual. Reactions without plasmid were prepared as the control. UDP-GlcNAz, UDP-5SGlcNAc (Ki = 8 μM), UDP, ThiametG (Ki = 21 nM) and MG132 were used at a final concentration of 75 μM, 200 μM, 200 μM, 50 μM and 25 μM, respectively. Before adding the plasmid to start the reaction, OGT OGA or proteasome inhibitors were incubated with RRL at RT for 10 min. Precipitation of peptidyl-tRNA by CTAB. Precipitation of peptidyl-tRNA was performed essentially as described51. Cell-free translation products (50 μl) were mixed with 500 μl of 2% (w/v) cetyltrimethylammonium bromide (CTAB) and vortexed. Then, 500 μl of 0.5 M sodium acetate (pH 5.4) and 100 μg of yeast tRNA (as carrier) were added to induce the precipitation of peptidyl-tRNA. After incubation at 30 °C for 10 min, the CTAB precipitates were collected by centrifugation at 17,000g for 10 min and then washed twice with 1 ml of acetone/HCl (19:1) to remove the CTAB. The precipitates were air dried and dissolved in 1× SDS-PAGE loading buffer. Expression of Sp1 or Nup62 in cells. HEK cells were maintained in highglucose DMEM (Gibco) supplemented with 10% FBS (Gibco), 100 IU/ml penicillin and 100 μg/ml streptomycin (Gibco). Transfection was carried out using the calcium phosphate precipitation method as described52. Plasmids (0.1 ml) were mixed with 0.5 ml of 0.25 M CaCl2, and then 0.5 ml of 2× BBS (50 mM BES, pH 6.95, 280 mM NaCl and 1.5 mM Na2HPO4) was added and mixed by pipetting immediately. After incubation for 15 min at room temperature, calcium phosphate-DNA mixture solution (1 ml) was added dropwise to cell culture in the 10-cm plate and swirled gently and placed in a tissue culture incubator. For transfections, 12 μg of plasmid encoding Sp1 or its mutants were used for each 10-cm plate, whereas 6 μg of plasmids encoding Nup62 or mutant Nup62 were used. For co-expression of HA-tagged ubiquitin, 6 μg of plasmid pRK5-HA-Ub was cotransfected at the same time as plasmids encoding Sp1 or Nup62 per 10-cm plate. 24 h after the transfection, cells were rinsed with growth medium, and new growth medium was provided. 8 h after replacing the medium, Ac4GalNAz or Ac45SGlcNAc in DMSO was added into cell cultures to yield 200-μM final concentrations of compounds, and equal amounts of DMSO alone were added to control cultures. Cells were cultured for a further 24 h before cells were harvested. MG132 was added 5 h before harvest to inhibit treated cultures as well as control cultures. OGT inducible knockout. The mouse embryonic fibroblast (MEF) cell line containing lentivirus encoding mutated estrogen receptor (mER)Cre-2A-GFP construct was a kind gift from N. Zachara (Johns Hopkins)35. Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM; 1 g/l glucose) with 10% (v/v) FBS (FBS) and 1% (v/v) penicillin/streptomycin at 37 °C in a water-jacketed, humidified CO2 (5%) incubator. Typically, cells were plated nature chemical biology at 10–25% confluency. Unless otherwise noted, Cre-recombinase was activated to knock out OGT through incubation with 0.7 μM 4-hydroxytamoxifen (4HT, Bioshop) 1 d after plating. 4HT was removed 24 h later. Cotransfection of Sp1 and HA-Ubiquitin was carried out 48 h after inducing OGT knockout using Turbofect transfection reagent (ThermoScientific), according to the manufacturer’s manual. MG132 was added 5 h before harvesting cells. Polysome extraction. To isolate polysomes from HEK cells, ~1.5 × 107 of cultured cells were rinsed with ice-cold PBS and then directly lysed in 2 ml ice-cold polysome lysis buffer containing 100 mM Tris (pH 7.4), 50 mM KCl, 25 mM MgCl2, 100 μg/ml cycloheximide, 1 mM DTT, 100 μM PMSF, 200 μg/ml heparin, 50 μM N-ethylmaleimide (NEM), 40 U/ml RNase inhibitor (Clontech), 1% Triton X-100 (Sigma-Aldrich) and cOmplete mini protease inhibitor cocktail mix (Roche). Lysates were clarified by centrifugation at 17,000g for 12 min at 4 °C, and the resulting supernatants were then layered on top of a 3-ml prechilled 35% sucrose cushion in buffer (10 mM Tris pH 7.4, 85 mM KCl and 5 mM MgCl2). After ultracentrifugation of the samples for 2 h at 60,000 r.p.m. in a Beckman Type 90 Ti Rotor at 4 °C, the polysomecontaining pellets were resuspended in 200 μl, pH 7.4, resuspension buffer containing 50 mM Tris, 100 mM NaCl, 2 mM EDTA, 1% SDS and cOmplete mini protease inhibitor cocktail mix (Roche). Total proteins in the polysomefree supernatant fractions were precipitated in 5 volumes of methanol at −80 °C overnight. After 16 h, the proteins were pelleted by centrifugation and then washed twice using 5 ml cold methanol. After air drying at RT, protein pellets were resuspended in resuspension buffer. Immunoprecipitation of ribosome-bound nascent polypeptides and mature proteins. Polysome extracts or the polysome-free fractions in resuspension buffer (200 μl) were mixed with an equal volume of cold lysis buffer (10 mM Tris, pH 8.04, 1 mM PMSF and 0.1% NP-40) and 3 volumes of cold nonionic detergent solution (50 mM Tris, pH 7.4, 100 mM NaCl, 2 mM EDTA, 1 mM PMSF, 1.66% Triton X-100, 3.3% BSA and protease inhibitor cocktail). The solution mixtures were then incubated with 30 μl of anti-Flag immunoprecipitation resin (Genscript) prewashed with PBS at 4 °C overnight. The resins were pelleted by centrifugation (5,000g, 2 min) and washed three times with buffer (pH 7.4, 10 mM Tris, 300 mM NaCl and 0.1% Triton X-100) and twice with PBS. Captured proteins were eluted in PBS using 100 μg/ml Flag peptide (75 μl) or by boiling directly in 1× SDS loading buffer (75 μl) for 10 min. Proteins immunoprecipitated were reacted overnight (16 h) with the biotin-diazo-phosphine probe 1 at room temperature. Cycloheximide chase. 48 h after transfection, HEK cells were incubated with 100 μg/ml of cycloheximide. Cells were harvested at the indicated time points as shown in Supplementary Figure 8, followed by cell lysis, SDS-PAGE and western blotting to visualize protein levels. Synthesis. Ac45SGlcNAc and UDP-5SGlcNAc were synthesized as described previously28. The cleavable biotin-diazo-phosphine probe 1 was synthesized as described in the Supplementary Note. UDP-GlcNAz was prepared as described26. Statistical analysis of the data. Immunoblot signals were quantified using Odyssey software (Li-Cor). Values of Flag, streptavidin or HA-Ub signals were normalized to immunoblot signals of the corresponding loading controls. All samples were normalized to the corresponding control, which was arbitrarily set at a value of one. Statistical analyses were carried out using Graphpad Prism 5.03. Data were analyzed using the paired Student’s t-test or one-way analysis of variance (ANOVA) when comparing more than two values. 51.Hobden, A.N. & Cundliffe, E. The mode of action of α-sarcin and a novel assay of the puromycin reaction. Biochem. J. 170, 57–61 (1978). 52.Chen, C. & Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745–2752 (1987). doi:10.1038/nchembio.1774
© Copyright 2024